Opinion 11 Aug 2021 Investors Turn to Biotechnology for a Sustainable Future The next industrial revolution is going to be a bio-revolution. It has to be, given that the byproducts of the original industrial revolution created the major pollution problems we now have to solve. But alongside the fixes, we also need to feed and heal a growing population efficiently and sustainably. The bio-revolution is already well […] August 11, 2021 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 26 Jul 2021 The Underlying Scientific Issues Making Biotech Startups Fail Biotech startups rely heavily on the science behind their products. There are a series of common scientific challenges that may initially be overlooked but can determine the success or failure of a young startup. Recently, a colleague drew my attention to a report about the top reasons a startup company might fail. After postmortems were […] July 26, 2021 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Expert Advice 5 Jul 2021 Why the Right Team is Key for Biotech Success For any startup, and especially for biotechnology startups, success depends on three main factors: science, financing, and people. One of the key factors investors look for is having a management team that can raise money and make good use of it to advance the science of the company. According to Sinclair Dunlop, Managing Partner at […] July 5, 2021 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 21 Jun 2021 A Window to the Past: Is the Biotech Investment Boom Going to Last? The biotech industry has been going through a period of fast growth in recent years. To uncover whether the current biotech investment boom will last, let’s look at what history can teach us. A window is something that opens and shuts. So the clear implication of everyone talking about a ‘public market window’ in the […] June 21, 2021 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 26 Apr 2021 How Good Investor Communications Determine Success in a Covid World During the pandemic, the biotech industry has continued to complete deals, even without face-to-face interactions. Startups should leverage communication to sustain their investor relations and build strong momentum for late-stage funding rounds in the coming years. Speaking last July, the UK’s Secretary of State for Health and Social Care, Matt Hancock, said the Covid-19 pandemic […] April 26, 2021 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 14 Apr 2021 DBV Battles Aimmune for Share of Peanut Allergy Treatment Market Last year, the FDA rejected DBV Technologies’ peanut allergy treatment and approved that of its rival Aimmune. After recent talks with the FDA and EMA, DBV has laid out a comeback plan that could carve it a niche in the peanut allergy treatment market. The French biotech firm DBV is coming back from a snub by […] April 14, 2021 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored by Merck 2 Mar 2021 How is Bioprocessing 4.0 Revolutionizing Biomanufacturing? The digital transformation of biopharmaceutical process development is known as Bioprocessing 4.0. Using the internet of things, digital biomanufacturing creates a network of data sources, materials, equipment, and industry representatives. This creates a competitive advantage, increases productivity, and boosts the value of biomanufacturing. We have spoken to Merrilee Whitney, Head of the BioContinuum™ platform at Merck* […] March 2, 2021 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Interview 22 Feb 2021 How Automation Can Augment Drug Discovery Research Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO and co-founder of Arctoris, discusses the benefits and challenges of introducing automation in drug discovery efforts. The Oxford-based startup Arctoris was established in 2016 with the objective of offering remote access to automated drug discovery. At a time when researchers […] February 22, 2021 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Expert Advice 14 Oct 2020 Everything You Need to Know About Biotech Business Models What’s my business model? Who do I partner with? How do I scale up? These are typical strategic questions a young biotech will regularly face. The business model of a biotech company can determine its long-term trajectory to success. In this article, we’ll focus on a typical ‘platform’ biotech company in the biopharma sector whose […] October 14, 2020 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 5 Oct 2020 The Complications Around Patenting Biotechnology Many people around the world start their mornings with a glass of orange juice. What these vitamin C drinkers might not know is that their ability to enjoy this tangy beverage stems from a victory within a complicated field of intellectual property law: biotechnology patents. Back in 1873, microbiologist Louis Pasteur patented a new yeast-making […] October 5, 2020 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2020 The Funding Flow Between European and US Life Sciences Funding is the lifeline of innovative ventures. In an increasingly uncertain environment, looking at the records of past investments can be essential for making sense of the future and getting closer to discovering what’s next for the life sciences industry. Exploring the differences between the two major groups of life sciences investors and the funding […] September 14, 2020 - 11 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Expert Advice 26 Aug 2020 Negotiating Early-Stage Biotech Valuation: VC vs Entrepreneur There is usually a big disparity between investors and entrepreneurs regarding the valuation of an early-stage biotech company. How can both sides navigate this negotiation and reach a fair agreement? Many entrepreneurs in biotech might be puzzled when they get a low pre-money valuation for a product with high potential. Even when a product in […] August 26, 2020 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email